First Time Loading...
A

Antares Pharma Inc
NASDAQ:ATRS

Watchlist Manager
Antares Pharma Inc
NASDAQ:ATRS
Watchlist
Price: 5.59 USD Market Closed
Updated: May 5, 2024

Antares Pharma Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Antares Pharma Inc
Net Income (Common) Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
A
Antares Pharma Inc
NASDAQ:ATRS
Net Income (Common)
$46.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Income (Common)
$38.5B
CAGR 3-Years
37%
CAGR 5-Years
21%
CAGR 10-Years
10%
Bristol-Myers Squibb Co
NYSE:BMY
Net Income (Common)
-$6.1B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Income (Common)
-$309m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Income (Common)
$2.3B
CAGR 3-Years
-31%
CAGR 5-Years
-23%
CAGR 10-Years
-7%
Eli Lilly and Co
NYSE:LLY
Net Income (Common)
$6.1B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
5%

See Also

What is Antares Pharma Inc's Net Income (Common)?
Net Income (Common)
46.3m USD

Based on the financial report for Dec 31, 2021, Antares Pharma Inc's Net Income (Common) amounts to 46.3m USD.

What is Antares Pharma Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
-18%

Over the last year, the Net Income (Common) growth was -18%.